Publikationen von M. E. Keck

Unschuld, P. G.; Ising, M.; Erhardt, A.; Lucae, S.; Kohli, M.; Kloiber, S.; Salyakina, D.; Thoeringer, C. K.; Lieb, R.; Uhr, M. et al.; Binder, E. B.; Müller-Myhsok, B.; Holsboer, F.; Keck, M. E.: Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder. Pharmacopsychiatry 40 (5), S. 217 - 217 (2007)

Erhardt, A.; Lucae, S.; Unschuld, P. G.; Ising, M.; Kern, N.; Salyakina, D.; Lieb, R.; Uhr, M.; Binder, E. B.; Keck, M. E. et al.; Müller-Myhsok, B.; Holsboer, F.: Association of polymorphisms in P2RX7 and CaMKKb with anxiety disorders. Journal of Affective Disorders 101 (1-3), S. 159 - 168 (2007)

Thoeringer, C. K.; Sillaber, I.; Roedel, A.; Erhardt, A.; Mueller, M. B.; Ohl, F.; Holsboer, F.; Keck, M. E.: The temporal dynamics of intrahippocampal corticosterone in response to stress-related stimuli with different emotional and physical load: An in vivo microdialysis study in C57BL/6 and DBA/2 inbred mice. Psychoneuroendocrinology 32 (6), S. 746 - 757 (2007)

Unschuld, P. G.; Ising, M.; Erhardt, A.; Lucae, S.; Kloiber, S.; Kohli, M.; Salyakina, D.; Welt, T.; Kern, N.; Lieb, R. et al.; Uhr, M.; Binder, E. B.; Müller-Myhsok, B.; Holsboer, F.; Keck, M. E.: Polymorphisms in the serotonin receptor gene HTR2A are associated with quantitative traits in panic disorder. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 144B (4), S. 424 - 429 (2007)

Thoeringer, C. K.; Binder, E. B.; Salyakina, D.; Erhardt, A.; Ising, M.; Unschuld, P. G.; Kern, N.; Lucae, S.; Brueckl, T. M.; Mueller, M. B. et al.; Fuchs, B.; Puetz, B.; Lieb, R.; Uhr, M.; Holsboer, F.; Mueller-Myhsok, B.; Keck, M.: Association of a Met88Val diazepam binding inhibitor (DBI) gene polymorphism and anxiety disorders with panic attacks. Journal of Psychiatric Research 41, doi:10.1016/j.jpsychires.2006.06.001, S. 579 - 584 (2007)

Welt, T.; Engelmann, M.; Renner, U.; Erhardt, A.; Müller, M. B.; Landgraf, R.; Holsboer, F.; Keck, M. E.: Temazepam triggers the release of vasopressin into the rat hypothalamic paraventricular nucleus: Novel insight into benzodiazepine action on hypothalamic-pituitary-adrenocortical system activity during stress. Neuropsychopharmacology 31 (12), S. 2573 - 2579 (2006)

Unschuld, P. G.; Erhardt, A.; Ising, M.; Lucae, S.; Kloiber, S.; Kohli, M.; Binder, E. B.; Müller-Myhsok, B.; Keck, M. E.; Holsboer, F.: An association candidate-gene study on genetic variations within HTR2A in patients suffering from panic disorder. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 141B (7), S. 739 - 740 (2006)

Nguyen, N. K.; Keck, M. E.; Hetzenauer, A.; Thöringer, C. K.; Wurst, W.; Deussing, J. M.; Holsboer, F.; Müller, M. B.; Singewald, N.: Conditional CRF receptor 1 knockout mice show altered neuronal activation pattern to mild anxiogenic challenge. Psychopharmacology 188 (3), S. 374 - 385 (2006)

Erhardt, A.; Ising, M.; Unschuld, P. G.; Kern, N.; Lucae, S.; Holsboer, F.; Keck, M. E.: Responsiveness of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder. Biological Psychiatry 59 (8 Suppl. S), S. 200S - 200S (2006)

Erhardt, A.; Unschuld, P. G.; Lucae, S.; Ising, M.; Salyakina, D.; Pütz, B.; Müller-Myhsok, B.; Binder, E. B.; Holsboer, F.; Keck, M. E.: Possible genetic implications of the endo-cannabinoid system in anxiety disorders versus depressive disorders. European Neuropsychopharmacology 16 (Suppl. 1), S. S88 - S88 (2006)

Erhardt, A.; Seaman, S. R.; Lucae, S.; Unschuld, P. G.; Kern, N.; Welt, T.; Ising, M.; Salyakina, D.; Pütz, B.; Lieb, R. et al.; Binder, E.; Müller-Myhsok, B.; Holsboer, F.; Keck, M. E.: Genetic implications of the endocannabinoid system in anxiety disorders versus depressive disorders: Is there any evidence for the continuum hypothesis? American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 138B (1), S. 44 - 44 (2005)

Kern, N.; Erhardt, A.; Pfennig, A.; Lucae, S.; Ising, M.; Salyakina, D.; Pütz, B.; Müller-Myhsok, B.; Uhr, M.; Holsboer, F. et al.; Binder, E. B.; Keck, M. E.: Syndromal panic attacks are possibly associated with polymorphisms in the angiotensin converting enzyme (ACE) gene. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 138B (1), S. 45 - 45 (2005)

Erhardt, A.; Seaman, S. R.; Lucae, S.; Kern, N.; Unschuld, P. G.; Welt, T.; Ising, M.; Salyakina, D.; Pütz, B.; Lieb, R. et al.; Binder, E. B.; Müller-Myhsok, B.; Holsboer, F.; Keck, M. E.: Genetic implications of the endocannabinoid system in anxiety disorders versus depressive disorders: is there any evidence for the continuum hypothesis? Pharmacopsychiatry 38 (5), S. 240 - 240 (2005)

Erhardt, A.; Unschuld, P. G.; Kern, N.; Welt, T.; Ising, M.; Keck, M. E.: Responsiveness of the hypothalamic-pituitary-adrenocortical system in patients with agoraphobia and panic attacks. Pharmacopsychiatry 38 (5), S. 240 - 240 (2005)

Thöringer, C. K.; Sillaber, I.; Harbich, D.; Uhr, M.; Holsboer, F.; Keck, M. E.: Distinct effects of chronic antidepressant treatment on anxiety and depression-related behavior and stress hormone system regulation in an inbred mouse model for affective disorders. Pharmacopsychiatry 38 (5), S. 280 - 280 (2005)

Unschuld, P. G.; Ising, M.; Erhardt, A.; Lucae, S.; Welt, T.; Kloiber, S.; Kern, N.; Salyakina, D.; Binder, E. B.; Brückl, T. et al.; Uhr, M.; Müller-Myhsok, B.; Holsboer, F.; Keck, M. E.: Polymorphisms in the serotonin receptor gene HTR2A modulate disease severity and susceptibility for anxiety disorders but not depression and are associated with specific personality traits. Pharmacopsychiatry 38 (5), S. 282 - 282 (2005)

Welt, T.; Rödel, A.; Ohl, F.; Erhardt, A.; Keck, M. E.: The explorative-reduced (EXR002) C3H mice - a new mouse model of depression? Pharmacopsychiatry 38 (5), S. 284 - 284 (2005)

Singewald, N.; Nguyen, N. K.; Hetzenauer, A.; Thöringer, C. K.; Wurst, W.; Deussing, J.; Müller, M. B.; Holsboer, F.; Keck, M. E.: Conditional Crh1 receptor knockout mice show altered neuronal activation pattern to mild anxiogenic challenge. Journal of Neurochemistry 94 (Suppl. 2), S. 230 - 230 (2005)

Keck, M. E.: Animal studies and the role of vasopressin and corticotropin-releasing hormone in anxiety. Biological Psychiatry 57 (8 Suppl. S), S. 156S - 156S (2005)

Keck, M. E.; Sartori, S. B.; Welt, T.; Müller, M. B.; Ohl, F.; Holsboer, F.; Landgraf, R.; Singewald, N.: Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment. Journal of Neurochemistry 92 (5), S. 1170 - 1179 (2005)